Luminex ($LMNX) won FDA clearance for a new diagnostic system that will help reach a wider range of patients with a key gastroenteritis fecal diagnostic test. The U.S ...
The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...
Children with autism have no unique pattern of abnormal results on endoscopy or other tests for gastrointestinal (GI) disorders, compared to non-autistic children with GI symptoms. Children with ...
BioFire Diagnostics won 510(k) clearance for its gastrointestinal panel for infectious diarrhea, following in the footsteps of the company's acquisition by French diagnostic giant bioMérieux.
Please provide your email address to receive an email when new articles are posted on . Testing correctly identified 79% of patients with GI cancer as positive. Nearly all (96%) of healthy controls ...
In the rapidly expanding landscape of molecular diagnostics, the focus is shifting from top to bottom, with a redirection from post-pandemic respiratory testing to developments in gastrointestinal (GI ...
A CT scan, computed tomography, takes multiple X-rays of the body from different angles in a very short period of time. These images are collected by a computer to give a series of "slices" of the ...
Hologic, Inc. HOLX recently received FDA 510(k) clearance for its Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. Additionally, the assays obtained CE marking in the ...
Gastrointestinal Diagnostics Market Gastrointestinal Diagnostics Market Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The ...
It’s not uncommon for GI conditions to be misdiagnosed. Here’s why. Bloating, gas, diarrhea, and abdominal pain are symptoms that could apply to any number of gastrointestinal (GI) conditions. It’s ...
A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results